American journal of obstetrics & gynecology MFM
-
Am J Obstet Gynecol MFM · May 2019
The association between 17-hydroxyprogesterone caproate use and postpartum hemorrhage.
To evaluate whether receipt of 17α-hydroxyprogesterone caproate within seven days of delivery is associated with increased risk of postpartum hemorrhage. ⋯ Recent receipt of 17α-hydroxyprogesterone caproate for prevention of recurrent preterm birth is not associated with risk of postpartum hemorrhage.